Isemid is a veterinary medicine used to treat signs related to congestive heart failure in dogs. Congestive heart failure is a condition when the heart cannot pump enough blood around the body. This can lead to exercise intolerance (inability to carry out physical activity), difficulty breathing and fluid retention. Isemid contains the active substance torasemide.
Isemid : EPAR - Medicine overview (PDF/75.54 KB)
First published: 07/02/2019
|Agency product number||
|International non-proprietary name (INN) or common name||
|Anatomical therapeutic chemical veterinary (ATCvet) codes||
CEVA Santé Animale
|Date of issue of marketing authorisation valid throughout the European Union||
10 avenue de La Ballastière
09/01/2019 Isemid - EMEA/V/C/004345 -
This medicine’s product information is available in all official EU languages.
Select ‘available languages’ to access the language you need.
Product information documents contain:
- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).
You can find product information documents for centrally authorised human medicines on this website. For centrally authorised veterinary medicines authorised or updated from February 2022, see the Veterinary Medicines Information website.
For treatment of clinical signs related to congestive heart failure in dogs, including pulmonary oedema.